LARP7通过增强线粒体生物合成保护心脏免受心力衰竭
本研究探讨LARP7在心力衰竭中的作用。在人类、非人灵长类和小鼠心衰模型中LARP7表达下调,低LARP7与活性氧升高、ATM介导的DNA损伤反应及LARP7泛素化降解相关。小鼠实验表明LARP7缺失导致线粒体生物合成受损和心衰,恢复LARP7可改善心肌梗死后的心脏功能,提示ATM-LARP7-SIRT1通路是心衰治疗靶点。
要点
- 心衰心脏中LARP7表达显著下调,与活性氧升高和ATM通路激活相关。
- LARP7缺失导致线粒体生物合成受损、氧化磷酸化障碍和心衰。
- 恢复LARP7或抑制ATM可改善心肌梗死后的心脏功能。
核心结论
- LARP7通过调节SIRT1稳态和活性对线粒体生物合成、能量产生和心脏功能至关重要。
- 疾病心脏中ATM通路激活导致LARP7减少,促进心衰发病,恢复LARP7可提供心肌保护。
- ATM-LARP7-SIRT1通路是心衰治疗干预的靶点。
研究设计与样本
- 评估人类心衰、非人灵长类和小鼠心衰模型中LARP7表达。
- 生成全身和心脏特异性LARP7敲除小鼠,并用Cas9介导的体细胞敲除在成熟心肌细胞中急性消除LARP7。
- 使用腺相关病毒血清型9过表达LARP7,并用ATM抑制剂处理心肌细胞。
- 在小鼠心肌梗死模型中测试LARP7调控通路的治疗潜力。
主要发现
- LARP7在人类心衰心脏及非人灵长类和小鼠心肌梗死后心脏中显著下调。
- 心衰心脏中低LARP7水平与活性氧升高相关,活性氧激活ATM介导的DNA损伤反应通路并促进LARP7泛素化和降解。
- 小鼠全身LARP7敲除导致线粒体生物合成受损、心肌发育不良和妊娠中期致死。
- 心脏特异性LARP7失活导致线粒体生物合成缺陷、氧化磷酸化受损、氧化应激升高和4月龄时心衰。
- 这些异常伴随SIRT1稳定性和脱乙酰酶活性降低,损害SIRT1介导的氧化磷酸化和能量代谢基因转录并抑制心脏功能。
临床怎么用
- ATM-LARP7-SIRT1通路可作为心衰治疗干预的潜在靶点。
- 恢复LARP7表达或抑制ATM可能改善心肌梗死后的心脏功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure (HF) is among the leading causes of morbidity and mortality, and its prevalence continues to rise. LARP7 (La ribonucleoprotein domain family member 7) is a master regulator that governs the DNA damage response and RNAPII (RNA polymerase II) pausing pathway, but its role in HF pathogenesis is incompletely understood. METHODS: We assessed LARP7 expression in human HF and in nonhuman primate and mouse HF models. To study the function of LARP7 in heart, we generated global and cardiac-specific LARP7 knockout mice. We acutely abolished LARP7 in mature cardiomyocytes by Cas9-mediated LARP7 somatic knockout. We overexpressed LARP7 in cardiomyocytes using adeno-associated virus serotype 9 and ATM (ataxia telangiectasia mutated protein) inhibitor. The therapeutic potential of LARP7-regulated pathways in HF was tested in a mouse myocardial infarction model. RESULTS: LARP7 was profoundly downregulated in failing human hearts and in nonhuman primate and murine hearts after myocardial infarction. Low LARP7 levels in failing hearts were linked to elevated reactive oxygen species, which activated the ATM-mediated DNA damage response pathway and promoted LARP7 ubiquitination and degradation. Constitutive LARP7 knockout in mouse resulted in impaired mitochondrial biogenesis, myocardial hypoplasia, and midgestational lethality. Cardiac-specific inactivation resulted in defective mitochondrial biogenesis, impaired oxidative phosphorylation, elevated oxidative stress, and HF by 4 months of age. These abnormalities were accompanied by reduced SIRT1 (silent mating type information regulation 2 homolog 1) stability and deacetylase activity that impaired SIRT1-mediated transcription of genes for oxidative phosphorylation and energy metabolism and dampened cardiac function. Restoring LARP7 expression after myocardial infarction by either adeno-associated virus-mediated LARP7 expression or small molecule ATM inhibitor substantially improved the function of injured heart. CONCLUSIONS: LARP7 is essential for mitochondrial biogenesis, energy production, and cardiac function by modulating SIRT1 homeostasis and activity. Reduction of LARP7 in diseased hearts owing to activation of the ATM pathway contributes to HF pathogenesis and restoring LARP7 in the injured heart confers myocardial protection. These results identify the ATM-LARP7-SIRT1 pathway as a target for therapeutic intervention in HF.
引用
- Yu H, Zhang F, Yan P, et al. LARP7 Protects Against Heart Failure by Enhancing Mitochondrial Biogenesis. Circulation. 2021. PMID: 33663221. doi:10.1161/CIRCULATIONAHA.120.050812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。